Large-scale AI-Ready Data for Anti-Cancer Drug Response Modeling
This work substantially expand the IMPROVE benchmark through large-scale integration of pharmacogenomic data, primarily from PharmacoDB, together with additional smaller data sources, which includes millions of drug response measurements, broader multi-omics coverage, and a major increase in chemical diversity, adding...
Vincent Lavelle, Yitan Zhu, Kaitlyn Marlor et al.
· 0 citations